State Of New Jersey Common Pension Fund D Revance Therapeutics, Inc. Transaction History

State Of New Jersey Common Pension Fund D

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	BUY	$24.7 - $37.61 $201,947 - $307,499	8,176 Added 11.64%	78,397 $1.98 Million
Q1 2023 Apr 26, 2023	SELL	$18.36 - $35.27 $587,281 - $1.13 Million	-31,987 Reduced 31.3%	70,221 $2.26 Million
Q4 2022 Feb 01, 2023	SELL	$18.32 - $30.66 $287,605 - $481,331	-15,699 Reduced 13.31%	102,208 $1.89 Million
Q3 2022 Oct 28, 2022	BUY	$14.33 - $28.47 $1.69 Million - $3.36 Million	117,907 New	117,907 $3.18 Million
Q2 2022 Aug 04, 2022	SELL	$11.52 - $20.4 $2.31 Million - $4.08 Million	-200,094 Closed	0 $0
Q1 2022 May 03, 2022	BUY	$12.36 - $20.31 $2.47 Million - $4.06 Million	200,094 New	200,094 $3.9 Million
Q4 2021 Jan 31, 2022	SELL	$12.46 - $27.87 $1.27 Million - $2.83 Million	-101,615 Closed	0 $0
Q3 2021 Oct 27, 2021	BUY	$25.78 - $33.21 $357,104 - $460,024	13,852 Added 15.78%	101,615 $2.83 Million
Q2 2021 Jul 23, 2021	BUY	$26.8 - $31.84 $125,209 - $148,756	4,672 Added 5.62%	87,763 $2.6 Million
Q4 2020 Feb 03, 2021	BUY	$23.41 - $28.34 $48,997 - $59,315	2,093 Added 2.58%	83,091 $2.36 Million
Q3 2020 Oct 27, 2020	SELL	$23.23 - $34.3 $304,405 - $449,467	-13,104 Reduced 13.93%	80,998 $2.04 Million
Q2 2020 Aug 04, 2020	BUY	$12.6 - $26.55 $1.19 Million - $2.5 Million	94,102 New	94,102 $2.3 Million
Q3 2019 Oct 23, 2019	SELL	$10.22 - $14.5 $265,720 - $377,000	-26,000 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$22.55 - $28.1 $586,300 - $730,600	26,000	26,000 $716,000

231

83.2M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.